Search for: "Laurence Lai" Results 181 - 200 of 706
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 May 2021, 5:21 am by Magnus Dahlman (Gulliksson)
The Court concluded that the only relevant circumstances in this respect was that Orifarm did not initiate revocation proceedings earlier after the decision laying down a preliminary injunction and that Orifarm only appealed one of its preliminary injunctions. [read post]
13 May 2021, 11:46 am by Matthieu Dhenne (Ipsilon)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Patents as an Incentive for… [read post]
13 May 2021, 11:45 am by Matthieu Dhenne (Ipsilon)
  More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Patents as an Incentive for… [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Patents as an Incentive for… [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Patents as an Incentive for… [read post]
10 May 2021, 3:57 pm by Thorsten Bausch (Hoffmann Eitle)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Patents as an Incentive for… [read post]
10 May 2021, 1:55 pm by William Ford, Matt Gluck
The committee will hear testimony from Laurence Korb, senior fellow at the Center for American Progress; Mandy Smithberger, director of the Center for Defense Information at the Project on Government Oversight; Ret. [read post]
Input by: Steve Zeman & Ralf Kirsch (Grünecker) More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 … [read post]
Input by: Steve Zeman & Ralf Kirsch (Grünecker) More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 … [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
  More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Patents as an Incentive for… [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 TRIPS and Access to Medicines: Pharmaceutical Patents and the Experience of Brazil by Renata Curzel€ 137 Patents as an Incentive for… [read post]
3 May 2021, 2:16 am by Lisa L. Mueller (Casimir Jones S.C.)
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 Handbook of Blockchain Law: A Guide to Understanding and Resolving the Legal Challenges of Blockchain Technology by Matthias Artzt, Thomas Richter€ 181 … [read post]
30 Apr 2021, 11:17 am by Kluwer Patent blogger
The ‘new normal’ at the EPO and more particularly plans to allow oral proceedings by videoconference even if parties don’t want it, have been leading to extensive debate over the last weeks. [read post]
30 Apr 2021, 11:17 am by Kluwer Patent blogger
The ‘new normal’ at the EPO and more particularly plans to allow oral proceedings by videoconference even if parties don’t want it, have been leading to extensive debate over the last weeks. [read post]
28 Apr 2021, 11:35 am by Matthieu Dhenne (Ipsilon)
In my last post I deciphered several fake news, which spoil the public debate about compulsory licensing, I then mentioned a bill proposal, introduced by Mr. [read post]
28 Apr 2021, 11:35 am by Matthieu Dhenne (Ipsilon)
In my last post I deciphered several fake news, which spoil the public debate about compulsory licensing, I then mentioned a French bill proposal, introduced by Mr. [read post]
More from our authors: Vissers Annotated European Patent Convention 2021 Edition by Laurence Lai, Derk Visser, Peter de Lange, Kaisa Suominen€ 105 Handbook of Blockchain Law: A Guide to Understanding and Resolving the Legal Challenges of Blockchain Technology by Matthias Artzt, Thomas Richter€ 181 … [read post]
16 Apr 2021, 1:05 am by Kluwer Patent blogger
The greatest challenge for IP in the area of artificial intelligence (AI) will be to achieve some level of harmonisation worldwide. [read post]
15 Apr 2021, 3:26 am by Thorsten Bausch (Hoffmann Eitle)
The European Patent Office has invited its users and stakeholders to take position on the first draft of its „Towards a new normal“ orientation document. [read post]